Skip to content

Clinical trials

Completed Triple Negative Breast Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Triple Negative Breast Neoplasms Status: Completed Country / region: Canada Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20102
20114
20134
20141
20153
20164
20179
20182
20192
20202
20212
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed38

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Novartis Pharmaceuticals5
Hoffmann-La Roche4
Merck Sharp & Dohme LLC4
AbbVie2
Pfizer2
Array Biopharma, now a wholly owned subsidiary of Pfizer1
Bayer1
Bristol-Myers Squibb1
Celgene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Triple Negative Breast Neoplasms38
Breast Neoplasms12
Carcinoma, Non-Small-Cell Lung10
Ovarian Neoplasms10
Neoplasms9
Pancreatic Neoplasms9
Neoplasm Metastasis7
Melanoma6
Colorectal Neoplasms5
Small Cell Lung Carcinoma5

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.